Related references
Note: Only part of the references are listed.Tumor Cell Clone Expressing the Membrane-bound Form of IL-12p35 Subunit Stimulates Antitumor Immune Responses Dominated by CD8+T Cells
Hoyong Lim et al.
Immune Network (2013)
Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
Manuela Gonzalez-Aparicio et al.
GUT (2011)
Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma
Quan-Yi Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
AntiTumor Mechanism of Recombinant Murine Interleukin-12 Vaccine
Xiaoling Yin et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
Mingli Xu et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression
Jeong-Im Sin
IMMUNOLOGY (2009)
CD3ζ Expression and T Cell Proliferation are Inhibited by TGF-β1 and IL-10 in Cervical Cancer Patients
Cinthya E. Diaz-Benitez et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally
Jason G. Fewell et al.
JOURNAL OF GENE MEDICINE (2009)
Correlation Between IL-10 Gene Expression and HPV Infection in Cervical Cancer: A Mechanism for Immune Response Escape
Victor H. Bermudez-Morales et al.
CANCER INVESTIGATION (2008)
Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates
Jay A. Lieberman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Interleukin-12: Biological properties and clinical application
Michele Del Vecchio et al.
CLINICAL CANCER RESEARCH (2007)
Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix
A. Sharma et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
E6 and E7 oncoproteins from Human Papillomavirus type 16 induce activation of human transforming growth factor ß1 promoter throughout Sp1 recognition sequence
Oscar Peralta-Zaragoza et al.
VIRAL IMMUNOLOGY (2006)
In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells
Juan Manuel Alcocer-Gonzalez et al.
VIRAL IMMUNOLOGY (2006)
A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors
LG Bermúdez-Humarán et al.
JOURNAL OF IMMUNOLOGY (2005)
A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CINIII lesions
AG Bais et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases
A Alves et al.
CANCER GENE THERAPY (2004)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers
KS Ryu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2001)
Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia
MY Tjiong et al.
CYTOKINE (2001)
Share Paper
